Androgen Receptor Expression in Androgen-independent Prostate Cancer Is Associated with Increased Expression of Androgen-regulated Genes1

The human prostate cancer (CaP) xenograft, CWR22, mimics human CaP. CWR22 grows in testosterone-stimulated nude mice, regresses after castration, and recurs after 5-6 months in the absence of testicular androgen. Like human CaP that recurs during androgen deprivation therapy, the recurrent CWR22 expresses high levels of androgen receptor (AR). Immunohistochemical, Western, and Northern blot analyses dem onstrated that AR expression in the androgen-independent CWR22 is similar to AR expression in the androgen-dependent CYYR22 prior to castration. Expression of prostate-specific antigen and human kallikrein-2 mRNAs, two well-characterized androgen-regulated genes in human CaP, was androgen dependent in CYVR22. Despite the absence of testicular androgen. prostate-specific antigen and human kallikrein-2 niRNA levels in recurrent CVVR22 were higher than the levels in regressing CWR22 tumors from 12-day castrate mice and similar to those in the androgenstimulated CWR22. Other AR-regulated genes followed a similar pattern of expression. Differential expression screening identified androgen reg ulation of a-enolase and ct-tubulin as well as other unknown mRNAs. Insulin-like growth factor binding protein-5, the homeobox gene \k.\ 3.1, the AR coactivator ARA-70, and cell cycle genes (tiki and Cdk2 were androgen regulated in CWR22. In recurrent CYVR22, the steady-state levels of all these AR-dependent mRNAs were similar to those in the androgen-stimulated CYVR22, despite the absence of testicular androgen. Expression of AR and AR-regulated genes in the androgen-deprived recurrent CWR22 at levels similar to the androgen-stimulated CWR22 suggests that AR is transcriptionally active in recurrent CWR22. Induc tion of these AR-regulated genes may enhance cellular proliferation in relative androgen absence but through an AR-dependent mechanism. Alternatively, in androgen-independent tumors, induced expression of the AR-regulated gene network might result from a non-AR transcription control mechanism common to these genes.

[1]  P. Gumerlock,et al.  Human androgen receptor expression in prostate cancer following androgen ablation. , 1997, European urology.

[2]  J. Pines Cyclins and their associated cyclin-dependent kinases in the human cell cycle. , 1993, Biochemical Society transactions.

[3]  F. S. French,et al.  A complex response element in intron 1 of the androgen-regulated 20-kDa protein gene displays cell type-dependent androgen receptor specificity. , 1993, The Journal of biological chemistry.

[4]  D. Tindall,et al.  Isolation and androgen regulation of the human homeobox cDNA, NKX3.1 , 1998, The Prostate.

[5]  H. Klocker,et al.  Synergistic activation of androgen receptor by androgen and luteinizing hormone‐releasing hormone in prostatic carcinoma cells , 1997, The Prostate.

[6]  D. Tindall,et al.  The mouse androgen receptor is suppressed by the 5'-untranslated region of the gene. , 1994, Molecular Endocrinology.

[7]  Jorma Isola,et al.  In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.

[8]  R. Matusik,et al.  Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. , 1993, Molecular endocrinology.

[9]  R. Franklin,et al.  Testosterone regulates mitochondrial aspartate aminotransferase gene expression and mRNA stability in prostate , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  J. Trapman,et al.  The rat androgen receptor gene promoter , 1990, Molecular and Cellular Endocrinology.

[11]  T. Ikonen,et al.  Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. , 1994, Endocrinology.

[12]  Desok Kim,et al.  Immunohistochemical quantitation of androgen receptor expression using color video image analysis. , 1999, Cytometry.

[13]  J. M. Kim,et al.  A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene. , 1993, The Journal of biological chemistry.

[14]  S. Schwartz,et al.  CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. , 1994, Cancer research.

[15]  J. Simard,et al.  Science behind total androgen blockade: from gene to combination therapy. , 1993, Clinical and investigative medicine. Medecine clinique et experimentale.

[16]  D. Tindall,et al.  Expression and androgenic regulation of human prostate-specific kallikreins. , 1995, Journal of andrology.

[17]  S. Mohan,et al.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. , 1997, Endocrine reviews.

[18]  K. Burnstein,et al.  Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA. , 1996, Molecular endocrinology.

[19]  R. Franklin,et al.  Testosterone regulates pyruvate dehydrogenase activity of prostate mitochondria. , 1993, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[20]  N. Kyprianou,et al.  Activation of programmed cell death in the rat ventral prostate after castration. , 1988, Endocrinology.

[21]  H. Klocker,et al.  Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. , 1995, European urology.

[22]  M. Gleave,et al.  Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. , 1992, Cancer research.

[23]  M. Shen,et al.  Tissue‐specific expression of murine Nkx3.1 in the male urogenital system , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  S. Schwartz,et al.  CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. , 1996, Cancer research.

[25]  F. S. French,et al.  Androgen receptor defects: historical, clinical, and molecular perspectives. , 1995, Endocrine reviews.

[26]  D. Tindall,et al.  Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP. , 1995, Endocrinology.

[27]  M. Gleave,et al.  Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline. , 1993, Cancer research.

[28]  C. Young,et al.  Defining a functional androgen responsive element in the 5' far upstream flanking region of the prostate-specific antigen gene. , 1997, Biochemical and biophysical research communications.

[29]  D. Grueneberg,et al.  Sequence-specific targeting of nuclear signal transduction pathways by homeodomain proteins , 1995, Molecular and cellular biology.

[30]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[31]  K. Hamil,et al.  Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. , 1997, Molecular endocrinology.

[32]  K. Hamil,et al.  Cloning of rat Sertoli cell follicle-stimulating hormone primary response complementary deoxyribonucleic acid: regulation of TSC-22 gene expression. , 1994, Endocrinology.

[33]  L. Nazareth,et al.  Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway* , 1996, The Journal of Biological Chemistry.

[34]  H. Willard,et al.  Cloning of human androgen receptor complementary DNA and localization to the X chromosome. , 1988, Science.

[35]  C. Huggins,et al.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.

[36]  A. Vershon Protein interactions of homeodomain proteins. , 1996, Current opinion in biotechnology.

[37]  F. S. French,et al.  The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. , 1988, Molecular endocrinology.

[38]  F. Berger,et al.  Androgen modulation of DNA-binding factors in the mouse kidney. , 1991, Molecular endocrinology.

[39]  A. Adler,et al.  Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Trapman,et al.  Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen Promoter (*) , 1996, The Journal of Biological Chemistry.

[41]  D. Tindall,et al.  Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene. , 1993, Biochemistry.

[42]  S. Yeh,et al.  Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. , 1994, Molecular endocrinology.

[43]  C. Bieberich,et al.  Prostate-specific and Androgen-dependent Expression of a Novel Homeobox Gene* , 1996, The Journal of Biological Chemistry.

[44]  L. Chung,et al.  A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans. , 1997, Molecular endocrinology.

[45]  W. Tilley,et al.  Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines. , 1990, The Journal of biological chemistry.

[46]  F. S. French,et al.  Response elements of the androgen-regulated C3 gene. , 1992, The Journal of biological chemistry.

[47]  C S Song,et al.  A distal activation domain is critical in the regulation of the rat androgen receptor gene promoter. , 1993, The Biochemical journal.

[48]  L. Matrisian,et al.  Epidermal growth factor or serum stimulation of rat fibroblasts induces an elevation in mRNA levels for lactate dehydrogenase and other glycolytic enzymes. , 1985, Nucleic acids research.

[49]  M. Santoro,et al.  Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. , 1994, Oncogene.

[50]  P. Carroll,et al.  Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki‐67 and PCNA expression , 1995, The Prostate.

[51]  W. Zhu,et al.  Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation. , 1997, Nucleic acids research.

[52]  S. Yeh,et al.  Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  T. H. van der Kwast,et al.  Androgen receptor expression in human tissues: an immunohistochemical study. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[54]  F. S. French,et al.  Androgen-dependent Protein Interactions within an Intron 1 Regulatory Region of the 20-kDa Protein Gene* , 1997, The Journal of Biological Chemistry.

[55]  R. T. Curtis,et al.  A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. , 1997, Genomics.

[56]  M. Tsai,et al.  Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. , 1997, Cancer research.

[57]  M. Mancini,et al.  Targeted overexpression of androgen receptor with a liver-specific promoter in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[58]  T. Brown,et al.  Identification and Characterization of a Novel Androgen Response Element Composed of a Direct Repeat* , 1997, The Journal of Biological Chemistry.

[59]  R. Ganschow,et al.  Androgen responsiveness of the murine beta-glucuronidase gene is associated with nuclease hypersensitivity, protein binding, and haplotype-specific sequence diversity within intron 9. , 1991, Molecular and cellular biology.

[60]  P. Chambon,et al.  Homeobox Genes in Embryogenesis and Pathogenesis , 1997, Pediatric Research.

[61]  M. Augustus,et al.  Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. , 1997, Cancer research.

[62]  J. Trapman,et al.  Synergism between androgens and protein kinase-C on androgen-regulated gene expression , 1995, Molecular and Cellular Endocrinology.

[63]  E. Wilson,et al.  The androgen receptor: an overview. , 1994, Recent progress in hormone research.

[64]  J Isola,et al.  Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. , 1997, Cancer research.